616
Participants
Start Date
January 18, 2024
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2028
RMC-6291
Oral tablet
RMC-6236
Oral tablet
Pembrolizumab
IV Infusion
Cisplatin
IV Infusion
Carboplatin
IV Infusion
Pemetrexed
IV infusion
RMC-9805
Oral Tablet
RECRUITING
Taipei Municipal Wanfang Hospital, Taipei
RECRUITING
The Netherlands Cancer Institute (NKI), Amsterdam
RECRUITING
University Medical Center Utrecht, Utrecht
RECRUITING
University Medical Centre Groningen, Groningen
RECRUITING
New York University Langone Health, New York
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Columbia University Medical Center, New York
RECRUITING
A.O.U. San Luigi Gonzaga-Orbassano - SCDU Oncologia Medica, Orbassano
RECRUITING
Clinical Research Alliance, Westbury
RECRUITING
Charite-Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin
RECRUITING
Centre François Baclesse, Caen
RECRUITING
Complejo Hospitalario Universitario A Coruña, A Coruña
RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
RECRUITING
Georgetown University Medical Center, Washington D.C.
RECRUITING
Fondazione IRCCS Istituto Nazionale dei tumori, Milan
RECRUITING
ASST Grande Ospedale Metropolitano Niguarda, Milan
RECRUITING
Centre Georges François Leclerc, Dijon
RECRUITING
NEXT Oncology Virginia, Fairfax
RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
RECRUITING
Hospital Clinico San Carlos, Madrid
RECRUITING
Hospital Universitario Fundacion Jimenez Diaz, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Regional Universitario de Malaga - Hospital Civil, Málaga
RECRUITING
Clinica Universidad de Navarra, Pamplona
RECRUITING
Oncopole Claudius Regaud, Toulouse
RECRUITING
Cancer Specialists of North Florida, Saint Augustine
RECRUITING
EDOG - Institut Bergonié, Bordeaux
RECRUITING
Boca Raton Clinical Research Associates, Plantation
RECRUITING
H Lee Moffitt Cancer Center and Research Institute, Tampa
RECRUITING
Lungenfachklinik Immenhausen, Immenhausen
RECRUITING
Baptist Medical Center, Memphis
RECRUITING
Hospital Universitario Virgen del Rocio - PPDS, Seville
RECRUITING
CHU de Nantes, Nantes
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Fundacion Instituto Valenciano de Oncologia, Valencia
RECRUITING
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
RECRUITING
"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l", Meldola
RECRUITING
Krankenhaus Bethanien Moers, Moers
RECRUITING
Ospedale Santa Maria Delle Croci, Ravenna
RECRUITING
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
RECRUITING
Uniklinik Köln, Cologne
RECRUITING
CHU de Lille Institut Cœur Poumon, Lille
RECRUITING
Intermountain Health - St. Vincent Frontier Cancer Center, Billings
RECRUITING
Universitätsklinikum Frankfurt, Frankfurt am Main
RECRUITING
Nebraska Cancer Specialist, Grand Island
RECRUITING
Thoraxklinik Heidelberg gGmbH - Universitätsklinikum Heidelberg, Heidelberg
RECRUITING
Hospices Civils de Lyon - Hôpital Louis Pradel, Bron
RECRUITING
Institut Curie, Paris
RECRUITING
NEXT Oncology Dallas, Irving
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
City of Hope - Duarte, Duarte
RECRUITING
University of California, San Diego Moores Cancer Center, San Diego
RECRUITING
Hopital Foch, Suresnes
RECRUITING
City of Hope - Lennar, Irvine
RECRUITING
UCSF Medical Center - Mission Bay, San Francisco
RECRUITING
Stanford University - Stanford Cancer Institute, Stanford
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
UC Davis, Davis Comprehensive Cancer Center, Sacramento
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden
RECRUITING
IRCCS Instituto Nazionale tumori Ragina Elena, Rome
RECRUITING
Fondazione Policlinico Universitario A Gemelli-Rome, Rome
RECRUITING
Leiden University Medical Center, Leiden
RECRUITING
Hospital Universitari Vall D' Hebron, Barcelona
RECRUITING
ICO Badalona - H.U. Germans Trias i Pujol, Barcelona
Revolution Medicines, Inc.
INDUSTRY